New pharma brands are tapping into old tried-and-true pharma ad strategies and investing big in TV advertising, according to the latest tracking report from iSpot.tv.
AbbVie’s Skyrizi for Crohn’s disease, Genentech’s Vabysmo and GSK’s Arexvy ranked as the top three newest “rising” pharma brands — those that weren’t on TV last year — in paid impressions during the third quarter, according to the real-time TV ad tracker.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.